Gero Luschin

Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial

Scott E. Kasner, Balakumar Swaminathan, Pablo M. Lavados et al. · The Lancet Neurology · 2018 · 177 citations · Full text

Prevalence of bisphosphonate-associated osteonecrosis of the jaw after intravenous zoledronate infusions in patients with early breast cancer

Petra Rugani, Gero Luschin, Norbert Jakse et al. · Clinical Oral Investigations · 2013 · 43 citations

Bone Disease, Breast Oncology, Intravenous Zoledronate Infusions +8

Tamoxifen and anastrozole as a sequencing strategy in postmenopausal women with hormone-responsive early breast cancer: updated data from the Austrian breast and colorectal cancer study group trial 8.

R. Jakesz, Michael Gnant, R Griel et al. · Cancer Research · 2009 · 29 citations

Breast Oncology, Cancer Management, Gynecology +19

WHO-definition of health must be enforced by national law: a debate

Marion Habersack, Gero Luschin · BMC Medical Ethics · 2013 · 26 citations · Full text

Macro-environment of breast carcinoma: frequent genetic alterations in the normal appearing skins of patients with breast cancer

Farid Moinfar, Alfred Beham, Gerhard Friedrich et al. · Modern Pathology · 2008 · 24 citations

Breast Oncology, Medicine, Melanoma +9